1 – 15 of 15
- show: 50
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2013
- Serum protein N-glycan alterations of diethylnitrosamine-induced hepatocellular carcinoma mice and their evolution after inhibition of the placental growth factor
- 2012
- Evaluation of inflammatory and angiogenic factors in patients with non-alcoholic fatty liver disease
- Serum protein N-glycosylation in paediatric non-alcoholic fatty liver disease
- Storage of blood samples at 4°C during one week does not affect protein glycosylation in healthy human volunteers
- N-glycan based biomarker distinguishing non-alcoholic steatohepatitis from steatosis independently of fibrosis
- 2011
-
Alterations of serum protein N-glycosylation in two mouse models of chronic liver disease are hepatocyte and not B cell driven
(2011) AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY. 300(5). p.G833-G842 Mark
- Inhibition of placental growth factor activity reduces the severity of fibrosis, inflammation, and portal hypertension in cirrhotic mice
- N-glycosylation of serum proteins in mouse models of chronic liver disease and in human conditions with liver disease.
- 2010
- The impact of elevation of total bilirubin level on serum N-glycosylation patterns in mice and men
- The impact of elevation of total bilirubin level on serum N-glycosylation patterns in mice and men
-
The impact of elevation of total bilirubin level and etiology of the liver disease on serum N-glycosylation patterns in mice and men
(2010) AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY. 298(5). p.G615-G624 Mark
- N-Glycosylation patterns of serum proteins to make the distinction between steatosis of the liver and non-alcoholic steatohepatitis in obese patients scheduled for bariatric surgery
- 2009
- Alteration of protein glycosylation in liver diseases
- 2008
- Different glycosylation patterns in mice models of portal hypertension and cirrhosis
- Different N-glycosylation patterns in mice models of portal hypertension and cirrhosis